"We found [that the stem cell] treated monkeys presented ... "Unfortunately, there is currently no effective treatment available to fundamentally restore ovarian function and improve fertility." ...

The therapeutic candidate is under development for the treatment of ovarian cancer. It comprises of induced pluripotent stem (iPS) cell derived natural killer (iNK) cell.

While gene therapy has emerged as a promising alternative for treating beta-thalassemia, hematopoietic stem cell ...

After years of controversy, stem cells are on the cusp of cures for conditions like epilepsy and type 1 diabetes.

Human Amniotic Epithelial Stem Cells is under clinical development by iCELL Biotechnology and currently in Phase I for Parkinson's Disease.

Dr. Sunita Tandulwadkar’s journey is a testament to her relentless pursuit of excellence, innovation, and service.

The findings are published in the journal Cancer Cell. The number of immune cells in a tumor has been shown to affect how patients respond to treatment ... same results in ovarian cancer.

A phase 1 trial evaluating FSHR-targeting CAR T cells for patients with ovarian cancer has dosed the first patient in its ...

Novel ADC shows activity in ovarian cancer Towards beta cell replacement therapy for diabetes! An upgraded pluripotent stem cell differentiation protocol is released Lurbinectedin, a new drug for ...